Works matching IS 09509232 AND DT 2008 AND VI 27

Results: 772

Soluble monomeric EphrinA1 is released from tumor cells and is a functional ligand for the EphA2 receptor.

Published in:

Oncogene, 2008, v. 27, n. 58, p. 7260, doi. 10.1038/onc.2008.328

By:

Wykosky, J.;
Palma, E.;
Gibo, D. M.;
Ringler, S.;
Turner, C. P.;
Debinski, W.

Publication type:

Article

Implication of human N-α-acetyltransferase 5 in cellular proliferation and carcinogenesis.

Published in:

Oncogene, 2008, v. 27, n. 58, p. 7296, doi. 10.1038/onc.2008.332

By:

Ametzazurra, A.;
Larrea, E.;
Civeira, M. P.;
Prieto, J.;
Aldabe, R.

Publication type:

Article

Repression of E-cadherin by the polycomb group protein EZH2 in cancer.

Published in:

Oncogene, 2008, v. 27, n. 58, p. 7274, doi. 10.1038/onc.2008.333

By:

Cao, Q.;
Yu, J.;
Dhanasekaran, S. M.;
Kim, J. H.;
Mani, R-S.;
Tomlins, S. A.;
Mehra, R.;
Laxman, B.;
Cao, X.;
Kleer, C. G.;
Varambally, S.;
Chinnaiyan, A. M.

Publication type:

Article

TTK/Mps1 controls nuclear targeting of c-Abl by 14-3-3-coupled phosphorylation in response to oxidative stress.

Published in:

Oncogene, 2008, v. 27, n. 58, p. 7285, doi. 10.1038/onc.2008.334

By:

Nihira, K.;
Taira, N.;
Miki, Y.;
Yoshida, K.

Publication type:

Article

Loss of Hus1 sensitizes cells to etoposide-induced apoptosis by regulating BH3-only proteins.

Published in:

Oncogene, 2008, v. 27, n. 58, p. 7248, doi. 10.1038/onc.2008.336

By:

Meyerkord, C. L.;
Takahashi, Y.;
Araya, R.;
Takada, N.;
Weiss, R. S.;
Wang, H-G.

Publication type:

Article

Ligand-dependent ubiquitination of Smad3 is regulated by casein kinase 1 gamma 2, an inhibitor of TGF-β signaling.

Published in:

Oncogene, 2008, v. 27, n. 58, p. 7235, doi. 10.1038/onc.2008.337

By:

Guo, X.;
Waddell, D. S.;
Wang, W.;
Wang, Z.;
Liberati, N. T.;
Yong, S.;
Liu, X.;
Wang, X-F.

Publication type:

Article

A role for candidate tumor-suppressor gene TCEAL7 in the regulation of c-Myc activity, cyclin D1 levels and cellular transformation.

Published in:

Oncogene, 2008, v. 27, n. 58, p. 7223, doi. 10.1038/onc.2008.360

By:

Chien, J.;
Narita, K.;
Rattan, R.;
Giri, S.;
Shridhar, R.;
Staub, J.;
Beleford, D.;
Lai, J.;
Roberts, L. R.;
Molina, J.;
Kaufmann, S. H.;
Prendergast, G. C.;
Shridhar, V.

Publication type:

Article

Targeting steroid hormone receptors for ubiquitination and degradation in breast and prostate cancer.

Published in:

Oncogene, 2008, v. 27, n. 57, p. 7201, doi. 10.1038/onc.2008.320

By:

Rodriguez-Gonzalez, A.;
Cyrus, K.;
Salcius, M.;
Kim, K.;
Crews, C. M.;
Deshaies, R. J.;
Sakamoto, K. M.

Publication type:

Article

Maspin modulates prostate cancer cell apoptotic and angiogenic response to hypoxia via targeting AKT.

Published in:

Oncogene, 2008, v. 27, n. 57, p. 7171, doi. 10.1038/onc.2008.321

By:

McKenzie, S.;
Sakamoto, S.;
Kyprianou, N.

Publication type:

Article

RAN GTPase is an effector of the invasive/metastatic phenotype induced by osteopontin.

Published in:

Oncogene, 2008, v. 27, n. 57, p. 7139, doi. 10.1038/onc.2008.325

By:

Kurisetty, V. V.;
Johnston, P. G.;
Johnston, N.;
Erwin, P.;
Crowe, P.;
Fernig, D. G.;
Campbell, F. C.;
Anderson, I. P.;
Rudland, P. S.;
El-Tanani, M. K.

Publication type:

Article

Inhibition of Src tyrosine kinase reverts chemoresistance toward 5-fluorouracil in human pancreatic carcinoma cells: an involvement of epidermal growth factor receptor signaling.

Published in:

Oncogene, 2008, v. 27, n. 57, p. 7212, doi. 10.1038/onc.2008.326

By:

Ischenko, I.;
Camaj, P.;
Seeliger, H.;
Kleespies, A.;
Guba, M.;
De Toni, E. N.;
Schwarz, B.;
Graeb, C.;
Eichhorn, M. E.;
Jauch, K.-W.;
Bruns, C. J.

Publication type:

Article

Androgen-induced programs for prostate epithelial growth and invasion arise in embryogenesis and are reactivated in cancer.

Published in:

Oncogene, 2008, v. 27, n. 57, p. 7180, doi. 10.1038/onc.2008.327

By:

Schaeffer, E. M.;
Marchionni, L.;
Huang, Z.;
Simons, B.;
Blackman, A.;
Yu, W.;
Parmigiani, G.;
Berman, D. M.

Publication type:

Article

Metabotropic glutamate receptor subtype-1 is essential for in vivo growth of melanoma.

Published in:

Oncogene, 2008, v. 27, n. 57, p. 7162, doi. 10.1038/onc.2008.329

By:

Ohtani, Y.;
Harada, T.;
Funasaka, Y.;
Nakao, K.;
Takahara, C.;
Abdel-Daim, M.;
Sakai, N.;
Saito, N.;
Nishigori, C.;
Aiba, A.

Publication type:

Article

Colorectal cancer cells with the BRAF<sup>V600E</sup> mutation are addicted to the ERK1/2 pathway for growth factor-independent survival and repression of BIM.

Published in:

Oncogene, 2008, v. 27, n. 57, p. 7150, doi. 10.1038/onc.2008.335

By:

Wickenden, J. A.;
Jin, H.;
Johnson, M.;
Gillings, A. S.;
Newson, C.;
Austin, M.;
Chell, S. D.;
Balmanno, K.;
Pritchard, C. A.;
Cook, S. J.

Publication type:

Article

Therapeutic targeting of Id2 reduces growth of human colorectal carcinoma in the murine liver.

Published in:

Oncogene, 2008, v. 27, n. 57, p. 7192, doi. 10.1038/onc.2008.356

By:

Gray, M. J.;
Dallas, N. A.;
Van Buren, G.;
Xia, L.;
Yang, A. D.;
Somcio, R. J.;
Gaur, P.;
Mangala, L. S.;
Vivas-Mejia, P. E.;
Fan, F.;
Sanguino, A. M.;
Gallick, G. E.;
Lopez-Berestein, G.;
Sood, A. K.;
Ellis, L. M.

Publication type:

Article

Guest Editors.

Published in:: Oncogene, 2008, v. 27, p. S1, doi. 10.1038/onc.2009.346
Publication type:: Article

Origins of cancer.

Published in:

Oncogene, 2008, v. 27, p. S2, doi. 10.1038/onc.2009.347

By:

Duesbery, N. S.;
MacKeigan, J. P.

Publication type:

Article

Identifying population-based approaches to lower breast cancer risk.

Published in:

Oncogene, 2008, v. 27, p. S3, doi. 10.1038/onc.2009.348

By:

Bernstein, L.

Publication type:

Article

Radiation carcinogenesis: lessons from Chernobyl.

Published in:

Oncogene, 2008, v. 27, p. S9, doi. 10.1038/onc.2009.349

By:

Williams, D.

Publication type:

Article

Clonally transmissible cancers in dogs and Tasmanian devils.

Published in:

Oncogene, 2008, v. 27, p. S19, doi. 10.1038/onc.2009.350

By:

Murchison, E. P.

Publication type:

Article

Human tumor-associated viruses and new insights into the molecular mechanisms of cancer.

Published in:

Oncogene, 2008, v. 27, p. S31, doi. 10.1038/onc.2009.351

By:

Martin, D.;
Gutkind, J. S.

Publication type:

Article

Common corruption of the mTOR signaling network in human tumors.

Published in:

Oncogene, 2008, v. 27, p. S43, doi. 10.1038/onc.2009.352

By:

Menon, S.;
Manning, B. D.

Publication type:

Article

MicroRNAs as potential cancer therapeutics.

Published in:

Oncogene, 2008, v. 27, p. S52, doi. 10.1038/onc.2009.353

By:

Trang, P.;
Weidhaas, J. B.;
Slack, F. J.

Publication type:

Article

Using biointelligence to search the cancer genome: an epistemological perspective on knowledge recovery strategies to enable precision medical genomics.

Published in:

Oncogene, 2008, v. 27, p. S58, doi. 10.1038/onc.2009.354

By:

Mousses, S.;
Kiefer, J.;
von Hoff, D.;
Trent, J.

Publication type:

Article

Guest Editor.

Published in:: Oncogene, 2008, v. 27, p. S1, doi. 10.1038/onc.2009.38
Publication type:: Article

BH3-only proteins in apoptosis and beyond: an overview.

Published in:

Oncogene, 2008, v. 27, p. S2, doi. 10.1038/onc.2009.39

By:

Lomonosova, E.;
Chinnadurai, G.

Publication type:

Article

BIK, the founding member of the BH3-only family proteins: mechanisms of cell death and role in cancer and pathogenic processes.

Published in:

Oncogene, 2008, v. 27, p. S20, doi. 10.1038/onc.2009.40

By:

Chinnadurai, G.;
Vijayalingam, S.;
Rashmi, R.

Publication type:

Article

egl-1: a key activator of apoptotic cell death in C. elegans.

Published in:

Oncogene, 2008, v. 27, p. S30, doi. 10.1038/onc.2009.41

By:

Nehme, R.;
Conradt, B.

Publication type:

Article

Bim and Bmf in tissue homeostasis and malignant disease.

Published in:

Oncogene, 2008, v. 27, p. S41, doi. 10.1038/onc.2009.42

By:

Piñon, J. D.;
Labi, V.;
Egle, A.;
Villunger, A.

Publication type:

Article

BAD: undertaker by night, candyman by day.

Published in:

Oncogene, 2008, v. 27, p. S53, doi. 10.1038/onc.2009.44

By:

Danial, N. N.

Publication type:

Article

PUMA, a potent killer with or without p53.

Published in:

Oncogene, 2008, v. 27, p. S71, doi. 10.1038/onc.2009.45

By:

Yu, J.;
Zhang, L.

Publication type:

Article

Noxa: at the tip of the balance between life and death.

Published in:

Oncogene, 2008, v. 27, p. S84, doi. 10.1038/onc.2009.46

By:

Ploner, C.;
Kofler, R.;
Villunger, A.

Publication type:

Article

Bid: a Bax-like BH3 protein.

Published in:

Oncogene, 2008, v. 27, p. S93, doi. 10.1038/onc.2009.47

By:

Billen, L. P.;
Shamas-Din, A.;
Andrews, D. W.

Publication type:

Article

The role of HRK gene in human cancer.

Published in:

Oncogene, 2008, v. 27, p. S105, doi. 10.1038/onc.2009.48

By:

Nakamura, M.;
Shimada, K.;
Konishi, N.

Publication type:

Article

BNIP3 subfamily BH3-only proteins: mitochondrial stress sensors in normal and pathological functions.

Published in:

Oncogene, 2008, v. 27, p. S114, doi. 10.1038/onc.2009.49

By:

Chinnadurai, G.;
Vijayalingam, S.;
Gibson, S. B.

Publication type:

Article

BH3-only proteins and their roles in programmed cell death.

Published in:

Oncogene, 2008, v. 27, p. S128, doi. 10.1038/onc.2009.50

By:

Giam, M.;
Huang, D. C. S.;
Bouillet, P.

Publication type:

Article

The autophagy effector Beclin 1: a novel BH3-only protein.

Published in:

Oncogene, 2008, v. 27, p. S137, doi. 10.1038/onc.2009.51

By:

Sinha, S.;
Levine, B.

Publication type:

Article

Mimicking the BH3 domain to kill cancer cells.

Published in:

Oncogene, 2008, v. 27, p. S149, doi. 10.1038/onc.2009.52

By:

Chonghaile, T. Ni;
Letai, A.

Publication type:

Article

Cardiac reanimation: targeting cardiomyocyte death by BNIP3 and NIX/BNIP3L.

Published in:

Oncogene, 2008, v. 27, p. S158, doi. 10.1038/onc.2009.53

By:

Dorn II, G. W.;
Kirshenbaum, L. A.

Publication type:

Article

BH3-only proteins in rheumatoid arthritis: potential targets for therapeutic intervention.

Published in:

Oncogene, 2008, v. 27, p. S168, doi. 10.1038/onc.2009.54

By:

Hutcheson, J.;
Perlman, H.

Publication type:

Article

Klotho: a tumor suppressor and a modulator of the IGF-1 and FGF pathways in human breast cancer.

Published in:

Oncogene, 2008, v. 27, n. 56, p. 7094, doi. 10.1038/onc.2008.292

By:

Wolf, I.;
Levanon-Cohen, S.;
Bose, S.;
Ligumsky, H.;
Sredni, B.;
Kanety, H.;
Kuro-o, M.;
Karlan, B.;
Kaufman, B.;
Koeffler, H. P.;
Rubinek, T.

Publication type:

Article

Prostate tumor progression is mediated by a paracrine TGF-β/Wnt3a signaling axis.

Published in:

Oncogene, 2008, v. 27, n. 56, p. 7118, doi. 10.1038/onc.2008.293

By:

Li, X.;
Placencio, V.;
Iturregui, J. M.;
Uwamariya, C.;
Sharif-Afshar, A.-R.;
Koyama, T.;
Hayward, S. W.;
Bhowmick, N. A.

Publication type:

Article

Regulation of androgen receptor transcriptional activity by rapamycin in prostate cancer cell proliferation and survival.

Published in:

Oncogene, 2008, v. 27, n. 56, p. 7106, doi. 10.1038/onc.2008.318

By:

Wang, Y.;
Mikhailova, M.;
Bose, S.;
Pan, C.-X.;
deVere White, R. W.;
Ghosh, P. M.

Publication type:

Article

Cyclin-dependent kinase 4/6 activity is a critical determinant of pre-replication complex assembly.

Published in:

Oncogene, 2008, v. 27, n. 56, p. 7083, doi. 10.1038/onc.2008.319

By:

Braden, W. A.;
McClendon, A. K.;
Knudsen, E. S.

Publication type:

Article

Oncogene activation in melanocytes links reactive oxygen to multinucleated phenotype and senescence.

Published in:

Oncogene, 2008, v. 27, n. 56, p. 7070, doi. 10.1038/onc.2008.323

By:

Leikam, C.;
Hufnagel, A.;
Schartl, M.;
Meierjohann, S.

Publication type:

Article

An inhibitor-resistant mutant of Hck protects CML cells against the antiproliferative and apoptotic effects of the broad-spectrum Src family kinase inhibitor A-419259.

Published in:

Oncogene, 2008, v. 27, n. 56, p. 7055, doi. 10.1038/onc.2008.330

By:

Pene-Dumitrescu, T.;
Peterson, L. F.;
Donato, N. J.;
Smithgall, T. E.

Publication type:

Article

CEACAM1, a SOX9 direct transcriptional target identified in the colon epithelium.

Published in:

Oncogene, 2008, v. 27, n. 56, p. 7131, doi. 10.1038/onc.2008.331

By:

Zalzali, H.;
Naudin, C.;
Bastide, P.;
Quittau-Prévostel, C.;
Yaghi, C.;
Poulat, F.;
Jay, P.;
Blache, P.

Publication type:

Article

Guest Editors.

Published in:: Oncogene, 2008, v. 27, n. 55, p. 6875, doi. 10.1038/onc.2008.338
Publication type:: Article

On the guardians of polarity and the disorientation of cancer.

Published in:

Oncogene, 2008, v. 27, n. 55, p. 6876, doi. 10.1038/onc.2008.339

By:

Banks, L;
Humbert, P O

Publication type:

Article

Par complex in cancer: a regulator of normal cell polarity joins the dark side.

Published in:

Oncogene, 2008, v. 27, n. 55, p. 6878, doi. 10.1038/onc.2008.340

By:

Aranda, V;
Nolan, M E;
Muthuswamy, S K

Publication type:

Article